Sbir topic 111, phase i, oxygen delivery device innovations

Ended Definitive Contract Awarded Last action

Contract number
75N92021C00031
Awardee
Awarding agency
Obligated
$299,964

Award facts

Contract value 100% obligated
$299,964.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Chelmsford, MA 01824, USA
Research
SBIR Program Phase I Action
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 · Closeout contract $0
Supplemental Agreement for work within scope P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $299,964

About this award

Triton Systems, Inc., a small business based in Chelmsford, Massachusetts, received a $299,964 firm fixed-price contract award from the National Heart, Lung, and Blood Institute (NHLBI) under the Small Business Innovation Research (SBIR) Program Phase I. This total small business set-aside contract, awarded on September 27, 2021, supported research and development efforts focused on oxygen delivery device innovations as part of SBIR Topic 111. The work was completed by the ultimate completion date of December 9, 2022, and the contract has since closed out. The SBIR program, administered by the National Institutes of Health in partnership with the Centers for Disease Control and Prevention, supports innovative research across biomedical and public health domains by enabling small businesses to conduct early-stage feasibility studies that demonstrate technical merit and commercial potential.

Triton Systems' selection for this award reflects the company's established capabilities in medical device development and technology commercialization. The contractor has a track record of securing multiple federal awards across diverse technological domains, including advanced medical technologies, aerospace systems, and environmental monitoring solutions. Through this NHLBI contract, Triton Systems advanced innovation in oxygen delivery technologies during the critical Phase I research phase, which typically focuses on establishing proof of concept and assessing commercial viability before potential progression to Phase II development and commercialization activities.

Quick answers

Who was awarded contract 75N92021C00031?

75N92021C00031 was awarded to Triton Systems, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 27, 2021.

How much is contract 75N92021C00031 worth?

The government has obligated $299,964 on 75N92021C00031.

Was contract 75N92021C00031 competed?

The extent of competition for 75N92021C00031 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award